Extracellular Signal-Regulated Kinases Modulate DNA Damage Response - A Contributing Factor to Using MEK Inhibitors in Cancer Therapy

The Raf-MEK-ERK pathway is commonly activated in human cancers, largely attributable to the extracellular signal-regulated kinases (ERKs) being a common downstream target of growth factor receptors, Ras, and Raf. Elevation of these up-stream signals occurs frequently in a variety of malignancies and...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, F, Yan, J, Tang, D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3330700/
https://www.ncbi.nlm.nih.gov/pubmed/22087839
http://dx.doi.org/10.2174/092986711798194388

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3330700/
https://www.ncbi.nlm.nih.gov/pubmed/22087839
http://dx.doi.org/10.2174/092986711798194388

Ejemplares similares